Despite advances in effective therapies, viral hepatitis rates continue to increase, especially among certain communities, identified as priority health populations. These populations include people who inject drugs (PWID), Asians/Pacific Islanders (APIs), American Indians/Alaska Natives (AIANs), and non-Hispanic Black persons. Furthermore, systemic barriers, stigma, and discrimination impede access to health services for people at increased risk for viral hepatitis. These factors contribute to missed/late diagnosis, onward transmission, costly tertiary care, and reduced quality of life. This collection of CME-certified activities provides strategies to overcome barriers and deliver equitable care to further the achievement of hepatitis elimination goals in the United States and worldwide.
Development of this product was supported with funding from the Centers for Disease Control and Prevention under cooperative agreement CDC-RFA-PS21-2105 "National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers," award #NU51PS005194.
AASLD is proud to participate as a contributing partner in this initiative, led and hosted by Medscape. The link below will take you to the library of content on the Medscape website.
https://www.medscape.org/viewcollection/36641?icd=login_success_email_match_norm